{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:04:32Z","timestamp":1776963872737,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006408","name":"Ministry of National Education and Religious Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bioorg.2020.104482","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:25:54Z","timestamp":1605615954000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of new raloxifene analogues of improved antagonist activity and endometrial safety"],"prefix":"10.1016","volume":"106","author":[{"given":"George","family":"Lambrinidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Gouedard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria","family":"Stasinopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Ganou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggeliki K.","family":"Meligova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra J.","family":"Mitsiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Marakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Pouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Mikros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael N.","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104482_b0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004143.pub5","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2020.104482_b0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2013.12.011","article-title":"Use of SERMs for treatment in postmenopausal women","volume":"142","author":"Pinkerton","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104482_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2014.07.013","article-title":"From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs)","volume":"90","author":"Wardell","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2020.104482_b0020","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor \u03b2","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2020.104482_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10311-006-0065-y","article-title":"The estrogen receptor and polyphenols: molecular simulation studies of their interactions, a review","volume":"4","author":"Lambrinidis","year":"2006","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104482_b0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/msb.2013.28","article-title":"Integrative genomics of gene and metabolic regulation by estrogen receptors \u03b1 and \u03b2, and their coregulators","volume":"9","author":"Madak-Erdogan","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bioorg.2020.104482_b0035","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"issue":"535","key":"10.1016\/j.bioorg.2020.104482_b0040","first-page":"e1","article-title":"Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)","volume":"205","author":"Runowicz","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bioorg.2020.104482_b0045","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bioorg.2020.104482_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/rtph.1997.1108","article-title":"Activity of raloxifene in immature and ovariectomized rat uterotrophic assays","volume":"25","author":"Ashby","year":"1997","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.bioorg.2020.104482_b0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/GME.0000000000000186","article-title":"Differential effects of menopausal therapies on the endometrium","volume":"21","author":"Mirkin","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.bioorg.2020.104482_b0060","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2020.104482_b0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/GME.0b013e318031a83d","article-title":"The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety","volume":"14","author":"Stovall","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.bioorg.2020.104482_b0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104482_b0075","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1093\/emboj\/18.17.4608","article-title":"Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist","volume":"18","author":"Pike","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2020.104482_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0969-2126(01)00568-8","article-title":"Structural insights into the mode of action of a pure antiestrogen","volume":"9","author":"Pike","year":"2001","journal-title":"Structure."},{"key":"10.1016\/j.bioorg.2020.104482_b0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.104482_b0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.molcel.2005.04.014","article-title":"Structural basis for an unexpected mode of SERM-mediated ER antagonism","volume":"18","author":"Wu","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2020.104482_b0095","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/acs.jmedchem.7b00585","article-title":"Adamantyl antiestrogens with novel side chains reveal a spectrum of activities in suppressing estrogen receptor mediated activities in breast cancer cells","volume":"60","author":"Min","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/acsmedchemlett.8b00106","article-title":"New class of selective estrogen receptor degraders (SERDs): expanding the toolbox of PROTAC degrons","volume":"9","author":"Wang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104482_b0105","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/jm00374a021","volume":"27","author":"Jones","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0110","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1016\/S0040-4039(99)00955-7","article-title":"Synergistic methodologies for the synthesis of 3-aroyl-2-arylbenzo[b]thiophene-based selective estrogen receptor modulators. Two concise syntheses of raloxifene","volume":"40","author":"Bradley","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2020.104482_b0115","unstructured":"J.A. Dodje, C.D. Jones, T.M.L. Bourgeois, Preparation of 3-[4-(2-heterocyclylethoxy)benzoyl-2-phenylbenzothiophenes for use in alleviating the symptoms of post-menopausal syndrome., Eur. Pat. Appl. (1996), 67pp. CODEN. EPXXDW EP 738725 A2 19961023 CAN 126: 7985 AN 1996: 740256 77, n.d."},{"key":"10.1016\/j.bioorg.2020.104482_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157017809787003133","article-title":"An efficient synthesis of raloxifene in ionic liquid: A green approach","volume":"6","author":"Shinde","year":"2009","journal-title":"LOC."},{"key":"10.1016\/j.bioorg.2020.104482_b0125","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1021\/jm020143r","article-title":"Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family","volume":"45","author":"Pandey","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0130","unstructured":"N. Shiyeyoshi, H. Kenji, S. Hidetaka, H. Takashi, O. Hiroyuki, T. Takeshi, S. Shinobu, Process for producing 3,4-dihydroquinazoline-4-one derivatives., PCT Int. Appl. (2003), 101pp PIXXD2 WO 2003064399, CAN 139:164805., n.d."},{"key":"10.1016\/j.bioorg.2020.104482_b0135","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/jm00117a010","article-title":"3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation","volume":"31","author":"Haviv","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0140","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1021\/np900271m","article-title":"Isoflavonoids from Erythrina poeppigiana : evaluation of their binding affinity for the Estrogen receptor","volume":"72","author":"Djiogue","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2020.104482_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-biophys-083012-130318","article-title":"Entropy-enthalpy compensation: role and ramifications in biomolecular ligand recognition and design","volume":"42","author":"Chodera","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.bioorg.2020.104482_b0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.chembiol.2004.02.014","article-title":"A new class of phytoestrogens: evaluation of the estrogenic activity of deoxybenzoins","volume":"11","author":"Fokialakis","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2020.104482_b0155","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.bmc.2012.03.012","article-title":"Ester and carbamate ester derivatives of Biochanin A: Synthesis and in vitro evaluation of estrogenic and antiproliferative activities","volume":"20","author":"Fokialakis","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ejmech.2009.12.006","article-title":"Synthesis of tropolone derivatives and evaluation of their in vitro neuroprotective activity","volume":"45","author":"Koufaki","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104482_b0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/anie.198603491","article-title":"First crystal structure analysis of an aliphatic carbocation\u2014stabilization of the 3,5,7-Trimethyl-1-adamantyl Cation by C-C hyperconjugation","volume":"25","author":"Laube","year":"1986","journal-title":"Angew. Chem. Int. Ed. Engl."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820317806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820317806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:07:21Z","timestamp":1758614841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820317806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"alternative-id":["S0045206820317806"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104482","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of new raloxifene analogues of improved antagonist activity and endometrial safety","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}